Evidence map›Paper›PMID 40771387›Full record

ArticleGland surgery2025

Integrating multimodal ultrasound imaging for improved radiomics sentinel lymph node assessment in breast cancer.

Zhe-Qin Yang, Yuan Zhang, Feng Lu, Tian Yang, Jun Shan, Quan Jiang, Geok Hoon Lim, François Bertucci, Hongbo Du, Yi-Cheng Zhu

Abstract read
In one paragraph

Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhe-Qin Yang *Department of Ultrasound, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Yuan Zhang *Department of Ultrasound, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Feng Lu *Department of Ultrasound, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, Shanghai, China.
Tian YangDepartment of Ultrasound, International Peace Maternity & Child Health Hospital of China Welfare Institute, Shanghai, China.
Jun ShanDepartment of Ultrasound, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Quan JiangDepartment of Ultrasound, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Geok Hoon LimBreast Department, KK Women's and Children's Hospital, Singapore, Singapore.
François BertucciDepartment of Medical Oncology, Cancer Research Center of Marseille, Paoli-Calmettes Institute, Aix-Marseille University, Marseille, France.
Hongbo DuSchool of Computing, University of Buckingham, Buckingham, UK.
Yi-Cheng ZhuDepartment of Ultrasound, Shanghai Pudong New Area People's Hospital, Shanghai, China.ORCID https://orcid.org/0000-0003-3037-0398

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate preoperative assessment of sentinel lymph node (SLN) is critical for treatment planning in breast cancer (BC). While SLN biopsy (SLNB) remains the gold standard, it is invasive and may be unnecessary for all patients, particularly those with clinically node-negative disease. Combining conventional B-mode ultrasound (BMUS) and color Doppler ultrasound (CDUS) with new techniques like radiomics and deep learning may improve SLN prediction, but this approach has not been widely studied yet. This retrospective study aims to develop and validate a deep learning radiomics model that combining BMUS and CDUS imaging to noninvasively predict SLN metastasis in patients with BC. Methods: A total of 450 women with invasive BC who were treated at 2 hospitals between October 2021 and March 2025 were retrospectively analyzed. Patients were divided into training (n=276), external validation (n=105), and testing (n=69) sets. Handcrafted features were extracted from the breast lesion areas and its surrounding areas in BMUS images. Deep learning-based features were derived by applying a fine-tuned dual-stream MobileNetV2-based model, ultrasound and color doppler network, to both BMUS and CDUS images. The extracted deep features were then subjected to dimensionality reduction using principal component analysis. Following this, both handcrafted and deep learning features underwent further feature selection and dimensionality reduction process via application of inter- and intraclass correlation coefficient filtering, Pearson correlation analysis, and least absolute shrinkage and selection operator (LASSO) regression. Three models were constructed: only handcrafted features (ONLY_HF), only deep-learning features (ONLY_DF), and combined features (COMB). Each model's performance was evaluated using the area under the curve (AUC). Results: The COMB model integrated ten features (six handcrafted and four deep learning) following LASSO regression. In predicting SLN metastasis between N0 and N≥1, COMB achieved a higher AUC (0.888, 0.861, and 0.837 in the training, validation, and testing sets, respectively) compared to ONLY_HF (0.792, 0.765, and 0.739) and ONLY_DF (0.781, 0.748, and 0.717). The negative prediction value of COMB was the highest (88.89%, 76.60%, and 71.23%), followed by ONLY_HF (83.33%, 72.00%, and 43.10%), and ONLY_DF (78.38%, 67.57%, and 52.69%). Conclusions: By integrating BMUS and CDUS imaging with advanced deep learning techniques, the COMB model achieved a high negative predictive value, which could guide axillary treatment decisions and reducing unnecessary invasive procedures. These findings highlight the potential of multimodal imaging and machine learning strategies to serve as noninvasive, supplementary tools for personalized BC management.

Indexed as

breast cancer (BC)deep learningSentinel lymph node metastasis (SLN metastasis)ultrasound

Identifiers

PMID40771387
PMCPMC12322757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.